tDCS in Post-stroke Neglect Rehabilitation
tDCS-Neglect
Transcranial Direct Current Stimulation as Coadjuvant Intervention in Post-stroke Neglect Rehabilitation
1 other identifier
interventional
30
1 country
1
Brief Summary
Introduction Stroke is the main cause of disability in the world and its sequelae have a great impact in the functional independence and quality of life of patients and families. Unilateral spatial neglect is one of the most frequent cognitive deficits after stroke, and its maintenance is associated with poor functional outcome of the rehabilitation process. For many years clinical research has been conducted to develop new and effective rehabilitation strategies for neglect. Noninvasive brain stimulation (NIBS) techniques are important tools in this regard, and it should be considered as a therapeutic intervention used in combination with conventional neuropsychological approaches. Transcranial direct current stimulation (tDCS) is a noninvasive, safe, neurophysiological technique able to modulate cortical activity by inducing a weak electric current into the brain. The studies focused on neglect symptoms treatment by means of tDCS over the lesional and contralesional hemisphere have shown promising results and its combination with conventional neglect therapies may enhance treatment efficacy and speed the recovery. Objectives To improve neglect symptoms by reducing the pathological hyperactivity of the undamaged hemisphere after right medial cerebral artery stroke, through the application of multisite tDCS, and to validate a NIBS protocol for the enhancement of conventional neuropsychological rehabilitation outcome. Methods The sample will be composed by 30 patients with spatial neglect secondary to a ischemic stroke in the middle cerebral artery in subacute stage (3 to 12 months since the event). The patients will be randomly assigned to one experimental group (Active, Sham, and Control). The intervention protocol consists in a two weeks intervention (10 sessions, 45 min, Monday to Friday) of tDCS and neuropsychological rehabilitation applied concurrently. In each session a 20 min tDCS at 2 milliamps (m will be applied over P3 according to 10/20 EEG international system (cathodal) with return electrodes placed in C3,CP5,CP1,Pz,PO3,PO7,P7 (10/20 EEG). StarStim® tDCS 8 channels Multisite device will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Nov 2019
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2019
CompletedFirst Submitted
Initial submission to the registry
November 12, 2019
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedNovember 9, 2022
November 1, 2022
4 years
November 12, 2019
November 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by The Bell Test (Gauthier, Dehaut, and Joanette 1989)
Pre and post intervention (3 days after the end of intervention)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by Copy of drawings subtest Barcelona test (Peña Casanova 2005)
Pre and post intervention (3 days after the end of intervention)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by Line bisection test (Schenkenberg, Bradford, and Ajax 1980)
Pre and post intervention (3 days after the end of intervention)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by The motor-free visual perception test (MVPT): (Colarusso, Hammill, and Academic Therapy Publications 1995)
Pre and post intervention (3 days after the end of intervention)
Change in functional independence
Change in functional independence assessed by The Catherine Bergego Scale (Azouvi et al. 2003)
Pre and post intervention (3 days after the end of intervention)
Change in functional independence
Change in functional independence assessed by Barthel Index (Mahoney and Barthel 1965)
Pre and post intervention (3 days after the end of intervention)
Change in general cognitive functioning
Change in general cognitive functioning assessed by Mini-mental state examination (MMSE) (Folstein, Folstein, and McHugh 1975)
Pre and post intervention (3 days after the end of intervention)
Change in neurophysiological assessment
Change in neurophysiological assessment through a resting state EEG acquisition. EEG will be recorded at rest using 64 electrodes in a system 10-20 distribution. An actiCHamp amplifier (Brain Vision LLC, North Carolina, United States) will be used to amplify and digitize the EEG data at a sampling frequency of 512 Hz. Alpha, Beta, Theta and Gamma bands will be recorded.
Pre and post intervention (3 days after the end of intervention)
Secondary Outcomes (1)
Side effects and patient comfort assessment
Pre and post session (before and at the end of every session - 1 min after the end of the session)
Study Arms (3)
Experimental group (Exp)
EXPERIMENTALActive tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation)
Sham-tDCS (Sham)
SHAM COMPARATORSham tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation
Control group (Control)
OTHERConventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation) without tDCS.
Interventions
The intervention consists in two-weeks treatment, 10 consecutive sessions of tDCS ( Monday to Friday) applied concurrently to neuropsychological rehabilitation. The tDCS Multisite StratStim® 8-channel device (Neuroelectrics) will be used for tDCS stimulation. The duration of the stimulation will be 20 minutes at 2 mA. The tDCS will be applied with the cathode positioned in P3 (following the international 10/20 EEG system), and the return electrodes will be placed in C3, CP5, CP1, Pz, PO3, PO7, P7. The sessions will last 1 hour.
The neuropsychological rehabilitation protocol has been designed for the recovery of neglect symptomatology. Each session will consist on the performance of different cognitive stimulation tasks aimed at improving attention and visoperceptive abilities. The tasks will be applied through the NeuronUp neurorehabilitation platform in order to achieve maximum homogeneity and objectivity across patients. The neuropsychological rehabilitation will last 30min (in 1h intervention session).
Eligibility Criteria
You may qualify if:
- Hemorrhagic or ischemic stroke in the right hemisphere.
- Stroke 3 to 12 months since the event (regardless of whether or not they have received prior rehabilitation).
- to 99 years-old.
- Neuroimaging study.
- Absence of previous strokes.
- Functional capacity that allows him/her to remain seated and active for one hour (Barthel Index score greater than 5 in the item of transfers between chair and bed; this item can be scored from 0 to 15, being 0 totally dependent and 15 totally independent).
- Right-handed manual dominance
- Neglect scores on at least two of the three tests administered for the assessment of visuospatial neglect.
- Signature of informed consent by the patient or his/her legal guardian.
You may not qualify if:
- Dermatological problems (psoriasis, dermatitis on the scalp or face).
- Presence of implants or metal parts in the head excluding fillings.
- Pacemakers, medication pumps, stimulators (vagal, cerebral, transcutaneous), ventriculoperitoneal shunts or aneurysm clips.
- Presence of previous strokes.
- Severe cognitive impairment assessed using the Mini-mental state examination (MMSE), excluding patients with scores under 24 (the score of MMSE are between 0 and 30, being 0 severe cognitive impairment and 30 no cognitive impairment).
- Significant language difficulties that not allow proper understanding of activities or severely limit expression.
- History of alcohol or drug abuse.
- Moderate or severe active depression.
- Uncontrolled medical problems (pathologies in acute phase without medical or pharmacological treatment with proven efficacy or pathologies with imminent life risk).
- Pregnancy or suspected pregnancy that will be checked by pregnancy test at the beginning of the study in patients of childbearing age and with the recommendation of the use of contraceptive methods until the end of the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitat Oberta de Catalunyalead
- Hospital Beata María Anacollaborator
- Universidad Francisco de Vitoriacollaborator
Study Sites (1)
Hospital Beata María Ana (Brain Damage Unit)
Madrid, 28007, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 12, 2019
First Posted
July 7, 2020
Study Start
November 8, 2019
Primary Completion
November 1, 2023
Study Completion
November 1, 2023
Last Updated
November 9, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share